DEB JORN

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

EyePoint Pharmaceuticals, Inc.

Filing Date Source Excerpt
2018-05-11 Deb Jorn 75,000 *

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-25